Quarterly report pursuant to Section 13 or 15(d)

NOTE 13 - STOCK OPTIONS AND WARRANTS

v2.4.0.8
NOTE 13 - STOCK OPTIONS AND WARRANTS
9 Months Ended
Sep. 30, 2013
Notes to Financial Statements  
Note 13 - STOCK OPTIONS

Options

 

On December 13, 2012, the Company ratified, confirmed and approved the granting of 2012 stock options in aggregate of 9,000,000 to Jorge Andrade, Neil Muller and Lourdes Felix, officers and directors of the Company under the Company’s 2012 Stock Option Plan. The issued options are exercisable immediately at $0.015 per share for five years.

 

On September 13, 2013, the Company ratified, confirmed and approved the granting of 2012 stock options in aggregate of 6,000,000 to Kent Emry, newly appointed CEO of the Company under the Company’s 2012 Stock Option Plan. The issued options are exercisable 50% immediately and 50% December 13, 2013 at $0.015 per share for five years.

 

The following table summarizes the changes in options outstanding and the related prices for the shares of the Company’s common stock issued to employees of the Company under the 2012 Stock Option Plan:

 

Options Outstanding     Options Exercisable  

Exercise

Prices

   

Number

Outstanding

   

Weighted Average

Remaining Contractual

Life (Years)

   

Weighted Average

Exercise Price

   

Number

Exercisable

   

Weighted

Average

Exercise Price

 
$ 0.015       15,000,000       4.40     $ 0.015       12,000,000     $ 0.015  
                                             

 

Transactions involving stock options issued to employees are summarized as follows:

 

   

Number of

Shares

   

Weighted Average

Exercise Price Per Share

 
Outstanding at January 1, 2012     -     $ -  
Granted     9,000,000       0.015  
Exercised     -       -  
Cancelled or expired     -       -  
Outstanding at December 31, 2012     9,000,000     $ 0.015  
Granted     6,000,000       0.015  
Exercised     -       -  
Expired     -       -  
Outstanding at September 30, 2013     15,000,000     $ 0.015  

As described above, on September 13, 2013, the Company granted 6,000,000 options to purchase the Company’s common stock at an exercise price of $0.015 per share for five years to the CEO with 50% immediate vesting and 50% on December 13, 2013. The fair value of options was determined using the Black Scholes Option Pricing Model with the following assumptions: dividend yield $-0-, volatility of 240.38% and risk free rate of 1.39%.

The Company recorded $114,109 and nil as stock compensation expense for the nine months ended September 30, 2013 and 2012, respectively. 

Warrants:

 

The following table summarizes the changes in warrants outstanding and the related prices for the shares of the Company’s common stock:

 

Warrants Outstanding     Options Exercisable  

Exercise

Prices

   

Number

Outstanding

   

Weighted Average

Remaining Contractual

Life (Years)

   

Weighted Average

Exercise Price

   

Number

Exercisable

   

Weighted

Average

Exercise Price

 
$ 1.00       425,000       4.51     $ 1.00       425,000     $ 1.00  
                                             

 

Transactions involving warrants are summarized as follows:

  

   

Number of

Shares

   

Weighted Average

Exercise Price Per Share

 
Outstanding at January 1, 2012     -     $ -  
Issued     -       -  
Exercised     -       -  
Cancelled or expired     -       -  
Outstanding at December 31, 2012     -     $ -  
Issued     425,000       1.00  
Exercised     -       -  
Expired     -       -  
Outstanding at September 30, 2013     425,000     $ 1.00  

 

As described in Note 8, above,  the Company issued detachable warrants granting the holder the right to acquire an aggregate of 425,000 shares of the Company’s common stock at an initial exercise price of $1.00 per share for five years.  The warrant contains exercise price adjustments in the event the Company issues additional shares of its common stock or securities convertible into the Company’s common stock at a price per share less than the exercise price in effect or without consideration, then the exercise price upon each issuance shall be adjusted to the price equal to the consideration per share paid for such additional shares of the Company’s common stock.